Title of Collaborative Activity: |
Advancing Regulatory Science through Novel Research and Science-Based Technologies |
Description of Collaborative Activity: |
NIH and FDA have formed an interagency partnership to foster regulatory science, a specialized and inter-disciplinary area of biomedical research that serves to generate new knowledge and tools for assessing experimental therapies, preventives, and diagnostics. A key goal of this Regulatory Science program is to accelerate the development and use of new tools, standards and approaches to efficiently develop products and to more effectively evaluate product safety, efficacy, and quality. |
Type of Collaborative Activity: |
Select Type of Collaborative Activity
|
Year the Collaborative Activity Originated: |
2010 |
NIH Participating Institutes/Centers/Office of the Director: |
NCATS, NEI, NHLBI, NIBIB, NIDDK, NINDS, OD/DPCPSI/OSC, OD/OSP |
HHS Agency Collaborators on this Activity: |
FDA |
